Natamycin Market by Form, Application, & Region | Forecast for 2023 to 2032

<p>The global <strong>natamycin market</strong> size is expected to reach <strong>US$ 61.0 Million</strong> in 2022 and further expand at a CAGR of <strong>6.8%</strong> throughout the forecast period (2022 to 2032). Overall natamycin sales are projected to surpass a total valuation of <strong>US$ 102.7 Million</strong> by the end of 2032.</p><table><tbody><tr><th scope='row'>Attribute</th><td>Key Insights</td></tr><tr><th scope='row'>Natamycin Market Estimated Value (2022E)</th><td>US$ 61.0 Million</td></tr><tr><th scope='row'>Projected Market Value (2033F)</th><td>US$ 102.7 Million</td></tr><tr><th scope='row'>Value-based CAGR (2022 to 2032)</th><td>6.8%</td></tr><tr><th scope='row'>USA Market Share</th><td>39.7%</td></tr></tbody></table><p>Scope of the Report</p><table><tbody><tr><th scope='row'>Attribute</th><td>Details</td></tr><tr><th scope='row'>Estimated Market Size (2022)</th><td>US$ 61.0 Million</td></tr><tr><th scope='row'>Projected Market Size (2032)</th><td>US$ 102.7 Million</td></tr><tr><th scope='row'>Anticipated Growth Rate (2022 to 2032)</th><td>6.8% CAGR</td></tr><tr><th scope='row'>Forecast Period</th><td>2022 to 2032</td></tr><tr><th scope='row'>Historical Data Available for</th><td>2017 to 2021</td></tr><tr><th scope='row'>Market Analysis</th><td>US$ Million for Value and Million. Sq. M. for Volume</td></tr><tr><th scope='row'>Key Regions Covered</th><td>North America, Latin America, Europe, East Asia, South Asia, and the Middle East &amp; Africa</td></tr><tr><th scope='row'>Key Countries Covered</th><td>USA, Brazil, Mexico, Germany, UK, China, India, Japan, Australia, and GCC Countries</td></tr><tr><th scope='row'>Key Segments Covered</th><td>Form, Application, and Region</td></tr><tr><th scope='row'>Key Companies Profiled</th><td><ul><li>DSM</li><li>Danisco</li><li>Handary</li><li>VGP</li><li>Silver-Elephant</li><li>AMTECH BIOTECH</li><li>Lanzhou Weiri</li><li>Zhengzhou New Frey</li><li>Langfang Meihua</li><li>Beijing Oriental Rada</li><li>Chihon</li><li>Jiaozuo Join care</li><li>Pucheng Life come</li></ul></td></tr><tr><th scope='row'>Report Coverage</th><td>Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives</td></tr></tbody></table>

<p>全球纳他霉素市场预计于2022年达到约61.0亿美元，并在预测期内（2022年至2032年）以6.8%的复合年增长率持续扩张。预计到2032年末，纳他霉素的整体销售额将超过102.7亿美元的总额。</p><table><tbody><tr><th scope='row'>属性</th><td>关键洞察</td></tr><tr><th scope='row'>纳他霉素市场预估价值（2022E）</th><td>61.0亿美元</td></tr><tr><th scope='row'>预测市场价值（2033F）</th><td>102.7亿美元</td></tr><tr><th scope='row'>基于价值的复合年增长率（2022至2032年）</th><td>6.8%</td></tr><tr><th scope='row'>美国市场份额</th><td>39.7%</td></tr></tbody></table><p>报告范围</p><table><tbody><tr><th scope='row'>属性</th><td>详细信息</td></tr><tr><th scope='row'>预估市场规模（2022年）</th><td>61.0亿美元</td></tr><tr><th scope='row'>预测市场规模（2032年）</th><td>102.7亿美元</td></tr><tr><th scope='row'>预期增长率（2022至2032年）</th><td>6.8% CAGR</td></tr><tr><th scope='row'>预测期</th><td>2022年至2032年</td></tr><tr><th scope='row'>可获取的历史数据</th><td>2017年至2021年</td></tr><tr><th scope='row'>市场分析</th><td>以百万美元计的价值和百万平方米的体积</td></tr><tr><th scope='row'>涵盖的关键地区</th><td>北美、拉丁美洲、欧洲、东亚、南亚和中东及非洲</td></tr><tr><th scope='row'>涵盖的关键国家</th><td>美国、巴西、墨西哥、德国、英国、中国、印度、日本、澳大利亚和GCC国家</td></tr><tr><th scope='row'>涵盖的关键细分市场</th><td>形式、应用和地区</td></tr><tr><th scope='row'>介绍的关键公司</th><td><ul><li>DSM</li><li>Danisco</li><li>Handary</li><li>VGP</li><li>Silver-Elephant</li><li>AMTECH BIOTECH</li><li>兰州威瑞</li><li>郑州新弗莱</li><li>廊坊梅花</li><li>北京东方雷达</li><li>智弘</li><li>焦作金康</li><li>濮城生命</li></ul></td></tr><tr><th scope='row'>报告覆盖</th><td>市场预测、公司份额分析、竞争情报、驱动因素、限制因素、机遇与威胁分析、市场动态与挑战、以及战略增长举措</td></tr></tbody></table>